Johnson & Johnson is leveraging artificial intelligence to significantly speed up its drug development process. The company has reported a dramatic reduction in analysis time, cutting it from 700 hours down to approximately 15 minutes. This advancement is expected to accelerate the overall timeline for bringing new medications to market. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT Accelerates pharmaceutical R&D timelines, potentially leading to faster drug approvals and market entry.
RANK_REASON AI application in a specific industry process with reported efficiency gains.
